CA Patent

CA3100834A1 — Formulations and methods for the prevention of opioid overdose

Assigned to Indivior Inc · Expires 2019-11-21 · 6y expired

What this patent protects

Formulations and methods for the preventative treatment of incidental opioid overdose comprising the intranasal (IN) administration of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.

USPTO Abstract

Formulations and methods for the preventative treatment of incidental opioid overdose comprising the intranasal (IN) administration of a pharmaceutical formulation containing the opioid antagonist nalmefene as a prophylactic measure.

Drugs covered by this patent

Patent Metadata

Patent number
CA3100834A1
Jurisdiction
CA
Classification
—
Expires
2019-11-21
Drug substance claim
No
Drug product claim
No
Assignee
Indivior Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.